Immunogenicity of a Whole-Cell Pertussis Vaccine with Low Lipopolysaccharide Content in Infants

Detalhes bibliográficos
Autor(a) principal: Zorzeto, Tatiane Queiroz
Data de Publicação: 2009
Outros Autores: Higashi, Hisako Gondo, Nolasco da Silva, Marcos Tadeu, Carniel, Emilia de Faria, Dias, Waldely de Oliveira [UNIFESP], Ramalho, Vanessa Domingues, Mazzola, Tais Nitsch, Batista Souza Lima, Simone Corte, Morcillo, Andre Moreno, Stephano, Marco Antonio, Reis de Goes Antonio, Maria Angela, Zanolli, Maria de Lurdes, Raw, Isaias, Santos Vilela, Maria Marluce dos
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1128/CVI.00339-08
http://repositorio.unifesp.br/handle/11600/31400
Resumo: The lack of a clear correlation between the levels of antibody to pertussis antigens and protection against disease lends credence to the possibility that cell-mediated immunity provides primary protection against disease. This phase I comparative trial had the aim of comparing the in vitro cellular immune response and anti-pertussis toxin (anti-PT) immunoglobulin G (IgG) titers induced by a cellular pertussis vaccine with low lipopolysaccharide (LPS) content (wP(low) vaccine) with those induced by the conventional whole-cell pertussis (wP) vaccine. A total of 234 infants were vaccinated at 2, 4, and 6 months with the conventional wP vaccine or the wP(low) vaccine. Proliferation of CD3(+) T cells was evaluated by flow cytometry after 6 days of peripheral blood mononuclear cell culture with stimulation with heat-killed Bordetella pertussis or phytohemagglutinin (PHA). CD3(+), CD4(+), CD8(+), and T-cell receptor gamma delta-positive (gamma delta(+)) cells were identified in the gate of blast lymphocytes. Gamma interferon, tumor necrosis factor alpha, interleukin-4 (IL-4), and IL-10 levels in super-natants and serum anti-PT IgG levels were determined using enzyme-linked immunosorbent assay (ELISA). the net percentage of CD3(+) blasts in cultures with B. pertussis in the group vaccinated with wP was higher than that in the group vaccinated with the wP(low) vaccine (medians of 6.2% for the wP vaccine and 3.9% for the wP(low) vaccine; P = 0.029). the frequencies of proliferating CD4(+), CD8(+), and gamma delta(+) cells, cytokine concentrations in supernatants, and the geometric mean titers of anti-PT IgG were similar for the two vaccination groups. There was a significant difference between the T-cell subpopulations for B. pertussis and PHA cultures, with a higher percentage of gamma delta(+) cells in the B. pertussis cultures (P < 0.001). the overall data did suggest that wP vaccination resulted in modestly better specific CD3(+) cell proliferation, and gamma delta(+) cell expansions were similar with the two vaccines.
id UFSP_703143987915513dd1d295679e85bfdf
oai_identifier_str oai:repositorio.unifesp.br/:11600/31400
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Immunogenicity of a Whole-Cell Pertussis Vaccine with Low Lipopolysaccharide Content in InfantsThe lack of a clear correlation between the levels of antibody to pertussis antigens and protection against disease lends credence to the possibility that cell-mediated immunity provides primary protection against disease. This phase I comparative trial had the aim of comparing the in vitro cellular immune response and anti-pertussis toxin (anti-PT) immunoglobulin G (IgG) titers induced by a cellular pertussis vaccine with low lipopolysaccharide (LPS) content (wP(low) vaccine) with those induced by the conventional whole-cell pertussis (wP) vaccine. A total of 234 infants were vaccinated at 2, 4, and 6 months with the conventional wP vaccine or the wP(low) vaccine. Proliferation of CD3(+) T cells was evaluated by flow cytometry after 6 days of peripheral blood mononuclear cell culture with stimulation with heat-killed Bordetella pertussis or phytohemagglutinin (PHA). CD3(+), CD4(+), CD8(+), and T-cell receptor gamma delta-positive (gamma delta(+)) cells were identified in the gate of blast lymphocytes. Gamma interferon, tumor necrosis factor alpha, interleukin-4 (IL-4), and IL-10 levels in super-natants and serum anti-PT IgG levels were determined using enzyme-linked immunosorbent assay (ELISA). the net percentage of CD3(+) blasts in cultures with B. pertussis in the group vaccinated with wP was higher than that in the group vaccinated with the wP(low) vaccine (medians of 6.2% for the wP vaccine and 3.9% for the wP(low) vaccine; P = 0.029). the frequencies of proliferating CD4(+), CD8(+), and gamma delta(+) cells, cytokine concentrations in supernatants, and the geometric mean titers of anti-PT IgG were similar for the two vaccination groups. There was a significant difference between the T-cell subpopulations for B. pertussis and PHA cultures, with a higher percentage of gamma delta(+) cells in the B. pertussis cultures (P < 0.001). the overall data did suggest that wP vaccination resulted in modestly better specific CD3(+) cell proliferation, and gamma delta(+) cell expansions were similar with the two vaccines.Univ Estadual Campinas, Sch Med, Ctr Investigat Pediat, BR-13083887 São Paulo, BrazilUniv Estadual Campinas, Sch Med, Dept Pediat, BR-13083887 São Paulo, BrazilButantan Inst, BR-05503900 São Paulo, BrazilUniv São Paulo, Fac Ciencias Farmaceut, BR-05508000 São Paulo, BrazilWeb of ScienceFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)Financiadora de Estudos e Projetos, BrazilFAPESP: 2005/03539-1Financiadora de Estudos e Projetos, Brazil: 01040957/0Amer Soc MicrobiologyUniversidade Estadual de Campinas (UNICAMP)Universidade Federal de São Paulo (UNIFESP)Butantan InstUniversidade de São Paulo (USP)Zorzeto, Tatiane QueirozHigashi, Hisako GondoNolasco da Silva, Marcos TadeuCarniel, Emilia de FariaDias, Waldely de Oliveira [UNIFESP]Ramalho, Vanessa DominguesMazzola, Tais NitschBatista Souza Lima, Simone CorteMorcillo, Andre MorenoStephano, Marco AntonioReis de Goes Antonio, Maria AngelaZanolli, Maria de LurdesRaw, IsaiasSantos Vilela, Maria Marluce dos2016-01-24T13:52:23Z2016-01-24T13:52:23Z2009-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion544-550application/pdfhttp://dx.doi.org/10.1128/CVI.00339-08Clinical and Vaccine Immunology. Washington: Amer Soc Microbiology, v. 16, n. 4, p. 544-550, 2009.10.1128/CVI.00339-08WOS000264938400017.pdf1556-6811http://repositorio.unifesp.br/handle/11600/31400WOS:000264938400017engClinical and Vaccine Immunologyinfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2024-08-07T19:08:32Zoai:repositorio.unifesp.br/:11600/31400Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652024-08-07T19:08:32Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Immunogenicity of a Whole-Cell Pertussis Vaccine with Low Lipopolysaccharide Content in Infants
title Immunogenicity of a Whole-Cell Pertussis Vaccine with Low Lipopolysaccharide Content in Infants
spellingShingle Immunogenicity of a Whole-Cell Pertussis Vaccine with Low Lipopolysaccharide Content in Infants
Zorzeto, Tatiane Queiroz
title_short Immunogenicity of a Whole-Cell Pertussis Vaccine with Low Lipopolysaccharide Content in Infants
title_full Immunogenicity of a Whole-Cell Pertussis Vaccine with Low Lipopolysaccharide Content in Infants
title_fullStr Immunogenicity of a Whole-Cell Pertussis Vaccine with Low Lipopolysaccharide Content in Infants
title_full_unstemmed Immunogenicity of a Whole-Cell Pertussis Vaccine with Low Lipopolysaccharide Content in Infants
title_sort Immunogenicity of a Whole-Cell Pertussis Vaccine with Low Lipopolysaccharide Content in Infants
author Zorzeto, Tatiane Queiroz
author_facet Zorzeto, Tatiane Queiroz
Higashi, Hisako Gondo
Nolasco da Silva, Marcos Tadeu
Carniel, Emilia de Faria
Dias, Waldely de Oliveira [UNIFESP]
Ramalho, Vanessa Domingues
Mazzola, Tais Nitsch
Batista Souza Lima, Simone Corte
Morcillo, Andre Moreno
Stephano, Marco Antonio
Reis de Goes Antonio, Maria Angela
Zanolli, Maria de Lurdes
Raw, Isaias
Santos Vilela, Maria Marluce dos
author_role author
author2 Higashi, Hisako Gondo
Nolasco da Silva, Marcos Tadeu
Carniel, Emilia de Faria
Dias, Waldely de Oliveira [UNIFESP]
Ramalho, Vanessa Domingues
Mazzola, Tais Nitsch
Batista Souza Lima, Simone Corte
Morcillo, Andre Moreno
Stephano, Marco Antonio
Reis de Goes Antonio, Maria Angela
Zanolli, Maria de Lurdes
Raw, Isaias
Santos Vilela, Maria Marluce dos
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade Estadual de Campinas (UNICAMP)
Universidade Federal de São Paulo (UNIFESP)
Butantan Inst
Universidade de São Paulo (USP)
dc.contributor.author.fl_str_mv Zorzeto, Tatiane Queiroz
Higashi, Hisako Gondo
Nolasco da Silva, Marcos Tadeu
Carniel, Emilia de Faria
Dias, Waldely de Oliveira [UNIFESP]
Ramalho, Vanessa Domingues
Mazzola, Tais Nitsch
Batista Souza Lima, Simone Corte
Morcillo, Andre Moreno
Stephano, Marco Antonio
Reis de Goes Antonio, Maria Angela
Zanolli, Maria de Lurdes
Raw, Isaias
Santos Vilela, Maria Marluce dos
description The lack of a clear correlation between the levels of antibody to pertussis antigens and protection against disease lends credence to the possibility that cell-mediated immunity provides primary protection against disease. This phase I comparative trial had the aim of comparing the in vitro cellular immune response and anti-pertussis toxin (anti-PT) immunoglobulin G (IgG) titers induced by a cellular pertussis vaccine with low lipopolysaccharide (LPS) content (wP(low) vaccine) with those induced by the conventional whole-cell pertussis (wP) vaccine. A total of 234 infants were vaccinated at 2, 4, and 6 months with the conventional wP vaccine or the wP(low) vaccine. Proliferation of CD3(+) T cells was evaluated by flow cytometry after 6 days of peripheral blood mononuclear cell culture with stimulation with heat-killed Bordetella pertussis or phytohemagglutinin (PHA). CD3(+), CD4(+), CD8(+), and T-cell receptor gamma delta-positive (gamma delta(+)) cells were identified in the gate of blast lymphocytes. Gamma interferon, tumor necrosis factor alpha, interleukin-4 (IL-4), and IL-10 levels in super-natants and serum anti-PT IgG levels were determined using enzyme-linked immunosorbent assay (ELISA). the net percentage of CD3(+) blasts in cultures with B. pertussis in the group vaccinated with wP was higher than that in the group vaccinated with the wP(low) vaccine (medians of 6.2% for the wP vaccine and 3.9% for the wP(low) vaccine; P = 0.029). the frequencies of proliferating CD4(+), CD8(+), and gamma delta(+) cells, cytokine concentrations in supernatants, and the geometric mean titers of anti-PT IgG were similar for the two vaccination groups. There was a significant difference between the T-cell subpopulations for B. pertussis and PHA cultures, with a higher percentage of gamma delta(+) cells in the B. pertussis cultures (P < 0.001). the overall data did suggest that wP vaccination resulted in modestly better specific CD3(+) cell proliferation, and gamma delta(+) cell expansions were similar with the two vaccines.
publishDate 2009
dc.date.none.fl_str_mv 2009-04-01
2016-01-24T13:52:23Z
2016-01-24T13:52:23Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1128/CVI.00339-08
Clinical and Vaccine Immunology. Washington: Amer Soc Microbiology, v. 16, n. 4, p. 544-550, 2009.
10.1128/CVI.00339-08
WOS000264938400017.pdf
1556-6811
http://repositorio.unifesp.br/handle/11600/31400
WOS:000264938400017
url http://dx.doi.org/10.1128/CVI.00339-08
http://repositorio.unifesp.br/handle/11600/31400
identifier_str_mv Clinical and Vaccine Immunology. Washington: Amer Soc Microbiology, v. 16, n. 4, p. 544-550, 2009.
10.1128/CVI.00339-08
WOS000264938400017.pdf
1556-6811
WOS:000264938400017
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Clinical and Vaccine Immunology
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 544-550
application/pdf
dc.publisher.none.fl_str_mv Amer Soc Microbiology
publisher.none.fl_str_mv Amer Soc Microbiology
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268368877780992